Yu Weinan, Zhang Jie, Chen Zhewen, Wang Shuai, Ruan Chuanxian, Zhou Wenli, Miao Mingyong, Shi Hanping
Departments of Endocrinology, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China.
Department of Nutrition, Zhejiang Provincial People's Hospital, Hangzhou, China.
Front Oncol. 2020 Oct 16;10:562189. doi: 10.3389/fonc.2020.562189. eCollection 2020.
This study aims to investigate the antitumor effect and the possible mechanism of a microecological preparation (JK5G) in mice. The mice treated with AOM/DSS were then randomly divided into the two model groups and the JK5G group, and the blank control group was included. Fecal samples were used for liquid chromatography-mass spectrometry and 16S rRNA gene sequencing analyses to reveal metabolic perturbations and gut flora disorders to demonstrate the effects of JK5G. Compared with the mice in the control group, the weight and food intake of mice after JK5G treatment were both upregulated. Moreover, JK5G could inhibit the growth of colon tumors and prolong the survival rate of mice, as well as inhibit the levels of cytokines in serum. The proportions of lymphocytes, T cells, CD3CD4 T cells, and CD3CD8 T cells in the spleen of the JK5G mice were all significantly increased compared to those in the control group ( < 0.05). Similarly, compared with the model group, the proportions of lymphocytes, B cells, T cells, natural killer T cells, CD3CD4 T cells, and CD3CD8 T cells in the intestinal tumors of the JK5G mice were significantly increased ( < 0.05). Furthermore, 16S rRNA high-throughput sequencing data revealed that in the JK5G group was significantly upregulated, and , , and were significantly downregulated. Fecal and serum metabolite analysis detected 939 metabolites, such as sildenafil and pyridoxamine, as well as 20 metabolites, including N-Palmitoyl tyrosine and dihydroergotamine, which were differentially expressed between the JK5G and model groups. Integrated analysis of 16s rRNA and metabolomics data showed that there were 19 functional relationship pairs, including 8 altered microbiota, such as and , and 16 disturbed metabolites between the JK5G and model groups. This study revealed that JK5G treatment was involved in the growth of colorectal cancer, which may be associated with the role of JK5G in improving the nutritional status of mice and regulating the tumor microenvironment by regulating the changes of intestinal microbiota and metabolite bands on different pathways.
本研究旨在探讨一种微生态制剂(JK5G)对小鼠的抗肿瘤作用及其可能机制。用AOM/DSS处理后的小鼠随即被随机分为两个模型组和JK5G组,并设空白对照组。采集粪便样本进行液相色谱 - 质谱联用和16S rRNA基因测序分析,以揭示代谢紊乱和肠道菌群失调情况,从而证明JK5G的作用效果。与对照组小鼠相比,JK5G处理后的小鼠体重和食物摄入量均上调。此外,JK5G可抑制结肠肿瘤生长,延长小鼠存活率,并抑制血清中细胞因子水平。与对照组相比,JK5G组小鼠脾脏中淋巴细胞、T细胞、CD3CD4 T细胞和CD3CD8 T细胞的比例均显著增加(P < 0.05)。同样,与模型组相比,JK5G组小鼠肠道肿瘤中淋巴细胞、B细胞、T细胞、自然杀伤T细胞、CD3CD4 T细胞和CD3CD8 T细胞的比例显著增加(P < 0.05)。此外,16S rRNA高通量测序数据显示,JK5G组中 显著上调,而 、 和 显著下调。粪便和血清代谢物分析检测到939种代谢物,如西地那非和吡哆胺,以及20种代谢物,包括N - 棕榈酰酪氨酸和双氢麦角胺,这些代谢物在JK5G组和模型组之间存在差异表达。16S rRNA和代谢组学数据的综合分析表明,JK5G组和模型组之间存在19个功能关系对,包括8种改变的微生物群,如 和 ,以及16种受干扰的代谢物。本研究表明,JK5G治疗参与了结直肠癌的生长,这可能与JK5G通过调节肠道微生物群变化和不同途径的代谢物谱来改善小鼠营养状况和调节肿瘤微环境的作用有关。